Atlas Trials

Mannkind Corporation

57 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Mannkind Corporation

RecordFirmDate
Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis (NCT07679893)Mannkind Corporation2026-06-30
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes (NCT07224321)Mannkind Corporation2026-02-04
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis (NCT07344558)Mannkind Corporation2025-12-22
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension (NCT06418711)Mannkind Corporation2024-09-11
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MKND-201 in Healthy Volunteers (NCT06532942)Mannkind Corporation2024-05-28
INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes (NCT05904743)Mannkind Corporation2023-07-07
Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes (NCT05243628)Mannkind Corporation2022-03-31
Afrezza® INHALE-1 Study in Pediatrics (NCT04974528)Mannkind Corporation2021-09-29
Afrezza® Dosing Optimization Study (NCT04849845)Mannkind Corporation2021-04-09
Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers (NCT03464864)Mannkind Corporation2018-03-09
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients (NCT02527265)Mannkind Corporation2017-09-28

Track Mannkind Corporation automatically

Every clearance here is in the API, with alerts when new ones post.